Vanguard Group’s Zepp Health ZEPP Stock Holding History

Vanguard Group’s Portfolio ZEPP Stock Details ZEPP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-2,685	Closed	-$138K	–	4223
2020 Q3	$138K	Buy	+2,685	New	+$147K	﹤0.01%	3986

Other funds holding ZEPP

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group's ZEPP Position: Q4 2020 in Review

Vanguard Group sold out of Zepp Health (ZEPP) in Q4 2020, closing a stake of 2,685 shares — an estimated $138K sold.

Vanguard Group first reported a position in ZEPP in Q3 2020 and held it in 1 quarter. The position peaked at $138K in Q3 2020. 56 funds tracked by Wall St. Rank hold ZEPP as of Q4 2020.

Vanguard Group reported no remaining Zepp Health position as of Q4 2020 after selling out during the quarter.
Vanguard Group sold 2,685 Zepp Health shares in Q4 2020, an estimated $138K.
Vanguard Group first reported a position in Zepp Health in Q3 2020 and held it in 1 quarter.
Vanguard Group's Zepp Health position peaked at $138K in Q3 2020.
56 funds tracked by Wall St. Rank held Zepp Health as of Q4 2020.

Based on Vanguard Group's 13F filing for Q4 2020, filed 12 Feb 2021.